Cerus Updates On INTERCEPT Red Blood Cell Programs In U.S. And EU
16 Oct 2024 //
BUSINESSWIRE
Cerus Announces Symposium and Abstracts at the 33rd Regional ISBT Congress
15 Jun 2023 //
BUSINESSWIRE
Cerus Corporation Celebrates World Blood Donor Day 2023
14 Jun 2023 //
BUSINESSWIRE
Cerus Announces Record Fourth Quarter and Full-Year 2022 Financial Results
28 Feb 2023 //
BUSINESSWIRE
Cerus Corporation to Participate in Upcoming Investor Conferences
10 Feb 2023 //
BUSINESSWIRE
Cerus Corporation Announces Award of U.S. Department of Defense Funding
02 Nov 2022 //
BUSINESSWIRE
Cerus Announces Workshop and Abstracts at the 2022 AABB Annual Meeting
26 Sep 2022 //
BUSINESSWIRE
Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public
12 Aug 2022 //
BUSINESSWIRE
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
21 Apr 2022 //
BUSINESSWIRE
Cerus Corporation to Release Second Quarter 2021 Financial Results
20 Jul 2021 //
BUSINESSWIRE
Cerus Corporation Celebrates World Blood Donor Day 2021
14 Jun 2021 //
BUSINESSWIRE
Cerus and Shandong Zhongbaokang Medical Implements Partner
24 Feb 2021 //
BUSINESSWIRE
Cerus Corporation Announces Presentation of Study Results with INTERCEPT
04 Dec 2020 //
BUSINESSWIRE
CERUS Announces the Acquisition of (LDO) by Opocrin SpA
29 Apr 2020 //
PR NEWSWIRE